FISH（蛍光 in situ ハイブリダイゼーション）市場レポート：動向、予測、競合分析 (2031年まで)

世界のFISH（蛍光 in situ ハイブリダイゼーション）市場の将来は、がん研究、遺伝子研究、感染症、個別化医療市場における機会で有望視されています。世界のFISH（蛍光 in situ ハイブリダイゼーション）市場は、2025年から2031年までのCAGRが7.6%で、2031年までに推定20億米ドルに達すると予想されています。この市場の主な促進要因は、がんや遺伝性疾患の患者数の増加とFISH製品の継続的な進歩です。

• Lucintelの予測では、製品種類別では消耗品が予測期間中最大のセグメントであり続けます。
• 用途別では、がん有病率の増加やがん研究に対する政府支援の高まりから、がん研究が最も高い成長を示すと予測されます。
• 地域別では、北米が乳がんや感染症治療の研究開発への投資が増加していることから、予測期間中も最大地域であり続けると思われます。

FISH（蛍光 in situ ハイブリダイゼーション）市場の戦略的成長機会

FISH（蛍光 in situ ハイブリダイゼーション）市場は、様々なアプリケーションにおいていくつかの戦略的成長機会を提示しています。概要は以下の通り：

• FISHは、特定の染色体異常や遺伝子変異の特定を可能にすることで、遺伝子研究の可能性を広げ、ゲノミクスや個別化医療分野のさらなる発展を支えます。
• がん診断：近年、がん診断がFISHの応用として台頭してきており、特にさまざまな種類のがんに関連する遺伝子マーカーを同定しています。これにより、がんの診断と治療計画の精度が向上します。
• 出生前スクリーニング：FISHは、妊娠初期の染色体異常を検出するための出生前スクリーニングでますます使用されるようになっており、早期介入を通じてより良い母体と胎児の健康管理をサポートしています。
• 感染症：感染症に特有の遺伝子配列を検出するためのFISHの応用が開発されており、病原体の特定や治療モニタリングのための迅速で高感度な診断ツールを提供しています。
• 医薬品開発：製薬研究におけるFISHは、研究者が遺伝子標的とその相互作用を研究することを可能にすることにより、新治療法の開発を加速し、医薬品開発を後押しします。

このような新たな機会は、いくつかの産業におけるFISH技術の応用を拡大し、市場の成長と革新を促進します。

FISH（蛍光 in situ ハイブリダイゼーション）市場促進要因・課題

これらの要因は、技術的、経済的、規制的な方法でFISH市場に影響を与えます。この後、主要な促進要因と課題が分析されます：

FISH（蛍光 in situ ハイブリダイゼーション）市場を牽引する要因は以下の通り：

• 技術進歩：FISH技術における多重化や高度なイメージングなどの革新は、FISHの能力と応用領域を強化し、市場の成長を促進します。
• 遺伝子検査需要の高まり：遺伝性疾患やがんの有病率の増加が、診断や研究におけるFISH技術の需要を押し上げています。
• 研究資金：ゲノムおよび分子生物学の研究分野への投資の増加が、FISH技術の開発と採用を刺激しています。
• 診断精度の向上：遺伝子情報の正確性を高めるFISHの能力は、臨床診断や調査研究への応用を高めています。

FISH（蛍光 in situ ハイブリダイゼーション）市場における課題は以下の通り：

• 高コスト：先進的なFISHシステムと試薬は非常に高価であるため、特に資源が乏しい環境では手が出ないか、導入が困難です。
• 技術の複雑さ：FISHに関する技術的な複雑さは、この技術に関する専門的なトレーニングと相まって、一部の検査室や臨床環境での採用を制限する可能性があります。

これらの市場促進要因・課題がFISH市場を牽引しており、ひいては成長見通しや業界利害関係者の戦略的意思決定に影響を及ぼしています。

目次

第1章 エグゼクティブサマリー

第2章 世界のFISH（蛍光 in situ ハイブリダイゼーション）市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析 (2019年～2031年)

• マクロ経済動向 (2019～2024年) と予測 (2025～2031年)
• 世界のFISH（蛍光 in situ ハイブリダイゼーション）市場の動向 (2019～2024年) と予測 (2025～2031年)
• 世界のFISH（蛍光 in situ ハイブリダイゼーション）市場：製品種類別
  • 消耗品
  • 装置
  • ソフトウェア
• 世界のFISH（蛍光 in situ ハイブリダイゼーション）市場：技術別
  • DNA FISH（蛍光 in situ ハイブリダイゼーション）
  • RNA FISH（蛍光 in situ ハイブリダイゼーション）
  • PNA FISH（蛍光 in situ ハイブリダイゼーション）
  • その他
• 世界のFISH（蛍光 in situ ハイブリダイゼーション）市場：用途別
  • がん研究
  • 遺伝子研究
  • 感染症
  • 個別化医療
  • その他
• 世界のFISH（蛍光 in situ ハイブリダイゼーション）市場：最終用途別
  • 病院・クリニック
  • 診断検査室
  • 製薬・バイオテクノロジー企業
  • CRO（医薬品開発業務受託機関）
  • 学術・研究機関
  • その他

第4章 地域別の市場動向と予測分析 (2019年～2031年)

• 世界のFISH（蛍光 in situ ハイブリダイゼーション）市場：地域別
• 北米のFISH（蛍光 in situ ハイブリダイゼーション）市場
• 欧州のFISH（蛍光 in situ ハイブリダイゼーション）市場
• アジア太平洋のFISH（蛍光 in situ ハイブリダイゼーション）市場
• その他地域のFISH（蛍光 in situ ハイブリダイゼーション）市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界のFISH（蛍光 in situ ハイブリダイゼーション）市場の成長機会：製品種類別
  • 世界のFISH（蛍光 in situ ハイブリダイゼーション）市場の成長機会：技術別
  • 世界のFISH（蛍光 in situ ハイブリダイゼーション）市場の成長機会：用途別
  • 世界のFISH（蛍光 in situ ハイブリダイゼーション）市場の成長機会：最終用途別
  • 世界のFISH（蛍光 in situ ハイブリダイゼーション）市場の成長機会：地域別
• 世界のFISH（蛍光 in situ ハイブリダイゼーション）市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のFISH（蛍光 in situ ハイブリダイゼーション）市場の生産能力拡大
  • 世界のFISH（蛍光 in situ ハイブリダイゼーション）市場における企業合併・買収 (M&A)、合弁事業
  • 認証とライセンシング

第7章 主要企業のプロファイル

• Abnova Corporation
• Agilent Technologies
• Biocare Medical
• Biodot
• F. Hoffmann-LA Roche
• Genemed Technologies
• Merck
• PERKINELMER
• Qiagen
• Thermos Fisher Scientific

The future of the global fluorescent in situ hybridization (FISH) market looks promising with opportunities in the cancer research, genetic research, infectious disease, and personalized medicine markets. The global fluorescent in situ hybridization (FISH) market is expected to reach an estimated $2 billion by 2031 with a CAGR of 7.6% from 2025 to 2031. The major drivers for this market are rising cases of cancer and genetic diseases and on-going advancements in FISH products.

• Lucintel forecasts that, within the product type category, consumables will remain the largest segment over the forecast period.
• Within the application category, cancer research is expected to witness the highest growth due to the increasing prevalence of cancer and rising government support for cancer research.
• In terms of regions, North America will remain the largest region over the forecast period due to growing investment in research and development of breast cancer and infectious disease treatment in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Fluorescent in Situ Hybridization (FISH) Market

The fluorescent in situ hybridization (FISH) market is evolving, with emerging trends rewriting its dynamics. Here's an overview of key trends:

• Multiplex Capabilities: The trend toward multiplex FISH assays allows for the simultaneous detection of multiple genetic targets, providing more in-depth and complete data from one sample. This enhances diagnostic and research applications by offering a wider view of genetic abnormalities.
• Automation Integration: The increased integration of automation within FISH procedures enhances laboratory efficiency and reproducibility. Automated systems streamline workflows, minimizing manual errors and accelerating the diagnostic process, which is essential for high-throughput environments.
• Advanced Probes and Dyes: New fluorescent probes and dyes are being developed to increase the specificity and sensitivity of FISH assays, enabling more precise detection of genetic abnormalities and enhancing research and clinical diagnostics.
• Digital Imaging: Advanced digital imaging methods currently being adopted in FISH promise higher resolution and more accurate analysis of fluorescent signals, enabling better data interpretation and more reliable results from genetic studies and diagnostics.
• Clinical Applications Expansion: In addition to cancer diagnostics, FISH technology is seeing increased application in other clinical settings related to genetic disorders and infectious diseases. This expansion in the scope of newer FISH applications further accelerates market growth.

These trends are driving innovation and expanding the applications of FISH technology, increasing its role in research and clinical diagnostics.

Recent Developments in the Fluorescent in Situ Hybridization (FISH) Market

The FISH market is a fast-evolving field where new technologies are being introduced and further applications explored. Some key developments are as follows:

• Multiplex FISH Assays: The development of multiplex FISH assays can detect multiple genetic targets in one sample, increasing diagnostic accuracy and enhancing the efficiency of genetic research studies and clinical diagnosis.
• Automated FISH Systems: The development of automated FISH systems enhances laboratory productivity by streamlining processes, reducing manual intervention, and improving the reproducibility of results.
• New Fluorescent Probes: Advancements in fluorescent probes are increasing the sensitivity and specificity of FISH assays, enabling more precise detection of genetic anomalies and facilitating detailed genetic research.
• High-Resolution Imaging: The incorporation of high-resolution imaging technologies in FISH provides clearer and more accurate visualization of fluorescence signals, leading to better analysis and interpretation of genetic data.
• Cost-Effective Solutions: The development of cost-effective solutions for FISH continues to be a primary focus area, making access to the technology feasible for more healthcare facilities and research institutions.

These factors further advance the capabilities and uses of FISH technology, acting as a driver for market growth.

Strategic Growth Opportunities for Fluorescent in Situ Hybridization (FISH) Market

The fluorescent in situ hybridization (FISH) market presents several strategic growth opportunities across various applications. An overview follows:

• FISH opens up wider genetic research possibilities by allowing for the specification of certain chromosomal abnormalities and gene mutations, which will support further advancements in the field of genomics and personalized medicine.
• Cancer Diagnostics: Recently, cancer diagnostics have emerged as a growing application of FISH, especially in identifying genetic markers associated with different types of cancer. This enhances the accuracy of cancer diagnoses and treatment planning.
• Prenatal Screening: FISH is increasingly used in prenatal screening to detect chromosomal abnormalities early in pregnancy, supporting better maternal and fetal health management through early intervention.
• Infectious Diseases: Applications of FISH are being developed for detecting genetic sequences unique to infectious diseases, providing a rapid, sensitive diagnostic tool for identifying pathogens and monitoring treatments.
• Pharmaceutical Development: FISH in pharmaceutical research boosts drug development by allowing researchers to study genetic targets and their interactions, thus speeding up the development of new therapies.

These emerging opportunities expand the applications of FISH technology in several industries, driving growth and innovation in the market.

Fluorescent in Situ Hybridization (FISH) Market Driver and Challenges

These factors influence the FISH market in a technological, economic, and regulatory manner. After this, major drivers and challenges are analyzed:

The factors responsible for driving the fluorescent in situ hybridization (fish) market include:

• Technological Advances: Innovations such as multiplexing and advanced imaging in FISH technology enhance the capability and areas of application of FISH, thus driving growth in the market.
• Rising Demand for Genetic Testing: Increased prevalence of genetic disorders and cancers is boosting the demand for FISH technology in diagnostics and research.
• Research Funding: Increasing investments in the fields of study within genomics and molecular biology stimulate the development and adoption of FISH technologies.
• Improved Diagnostic Accuracy: The capability of FISH to avail the accuracy of genetic information heightens its applications within clinical diagnosis and research studies.

Challenges in the fluorescent in situ hybridization (fish) market are:

• High Costs: Advanced FISH systems and reagents are very expensive; thus, it becomes unaffordable or difficult to adopt, especially in resource-poor settings.
• Complexity of Techniques: Technical complexities with regard to FISH are coupled with specialized training in this technique that may limit its adoption in some laboratories and clinical settings.

These drivers and challenges are driving the FISH market, which, in turn, influences growth prospects and the strategic decisions of industry stakeholders.

List of Fluorescent in Situ Hybridization (FISH) Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies fluorescent in situ hybridization (FISH) companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the fluorescent in situ hybridization (FISH) companies profiled in this report include-

• Abnova Corporation
• Agilent Technologies
• Biocare Medical
• Biodot
• F. Hoffmann-LA Roche
• Genemed Technologies
• Merck
• PERKINELMER
• Qiagen
• Thermos Fisher Scientific

Fluorescent in Situ Hybridization (FISH) by Segment

The study includes a forecast for the global fluorescent in situ hybridization (FISH) market by product type, technology, application, end use, and region.

Fluorescent in Situ Hybridization (FISH) Market by Product Type [Analysis by Value from 2019 to 2031]:

• Consumables
• Instrument
• Software

Fluorescent in Situ Hybridization (FISH) Market by Technology [Analysis by Value from 2019 to 2031]:

• DNA Fluorescent in Situ Hybridization
• RNA Fluorescent in Situ Hybridization
• PNA Fluorescent in Situ Hybridization
• Others

Fluorescent in Situ Hybridization (FISH) Market by Application [Analysis by Value from 2019 to 2031]:

• Cancer Research
• Genetic Research
• Infectious Disease
• Personalized Medicine
• Others

Fluorescent in Situ Hybridization (FISH) Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals & Clinics
• Diagnostic Laboratories
• Pharmaceuticals & Biotechnology Companies
• Contract Research Organizations
• Academic & Research Organizations
• Others

Fluorescent in Situ Hybridization (FISH) Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Fluorescent in Situ Hybridization (FISH) Market

The FISH market is currently experiencing significant development due to technological innovations and expanded applications in genetic research and diagnostics. A brief overview of recent developments in major economies is provided below:

• United States: The U.S. is witnessing developments in FISH technologies, especially multiplex FISH assays, which have the capability to identify several targets simultaneously. This improves research and clinical diagnostics by providing more complete data.
• China: China is developing its FISH market by investing more in genomic studies and research and development, focusing on improving access and affordability of FISH products to support wider adoption in both clinical and research settings.
• Germany: Germany is at the forefront of innovation in high-resolution FISH techniques and automation solutions. Such innovations improve the precision of genetic analyses and facilitate the simplification of laboratory workflows, which is crucial for both research and clinical applications.
• India: Advances in molecular diagnostics and cancer research are driving the application of FISH technology in India. Current efforts focus on developing affordable FISH solutions to meet the demand from a growing patient pool.
• Japan: Japan is advancing FISH technology with novel fluorescent probes and imaging methods. These innovations enhance the specificity and sensitivity of FISH assays, making them increasingly suitable for genetic and oncological research.

Features of the Global Fluorescent in Situ Hybridization (FISH) Market

Market Size Estimates: Fluorescent in situ hybridization (FISH) market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Fluorescent in situ hybridization (FISH) market size by various segments, such as by product type, technology, application, end use, and region in terms of value ($B).

Regional Analysis: Fluorescent in situ hybridization (FISH) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the fluorescent in situ hybridization (FISH) market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the fluorescent in situ hybridization (FISH) market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M&A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the fluorescent in situ hybridization (FISH) market by product type (consumables, instrument, and software), technology (DNA fluorescent in situ hybridization, RNA fluorescent in situ hybridization, PNA fluorescent in situ hybridization, and others), application (cancer research, genetic research, infectious disease, personalized medicine, and others), end use (hospitals & clinics, diagnostic laboratories, pharmaceuticals & biotechnology companies, contract research organizations, academic & research organizations, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Fluorescent in Situ Hybridization (FISH) Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Fluorescent in Situ Hybridization (FISH) Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Fluorescent in Situ Hybridization (FISH) Market by Product Type
  • 3.3.1: Consumables
  • 3.3.2: Instrument
  • 3.3.3: Software
• 3.4: Global Fluorescent in Situ Hybridization (FISH) Market by Technology
  • 3.4.1: DNA Fluorescent in Situ Hybridization
  • 3.4.2: RNA Fluorescent in Situ Hybridization
  • 3.4.3: PNA Fluorescent in Situ Hybridization
  • 3.4.4: Others
• 3.5: Global Fluorescent in Situ Hybridization (FISH) Market by Application
  • 3.5.1: Cancer Research
  • 3.5.2: Genetic Research
  • 3.5.3: Infectious Disease
  • 3.5.4: Personalized Medicine
  • 3.5.5: Others
• 3.6: Global Fluorescent in Situ Hybridization (FISH) Market by End Use
  • 3.6.1: Hospitals & Clinics
  • 3.6.2: Diagnostic Laboratories
  • 3.6.3: Pharmaceuticals & Biotechnology Companies
  • 3.6.4: Contract Research Organizations
  • 3.6.5: Academic & Research Organizations
  • 3.6.6: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Fluorescent in Situ Hybridization (FISH) Market by Region
• 4.2: North American Fluorescent in Situ Hybridization (FISH) Market
  • 4.2.1: North American Market by Product Type: Consumables, Instrument, and Software
  • 4.2.2: North American Market by Application: Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Others
• 4.3: European Fluorescent in Situ Hybridization (FISH) Market
  • 4.3.1: European Market by Product Type: Consumables, Instrument, and Software
  • 4.3.2: European Market by Application: Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Others
• 4.4: APAC Fluorescent in Situ Hybridization (FISH) Market
  • 4.4.1: APAC Market by Product Type: Consumables, Instrument, and Software
  • 4.4.2: APAC Market by Application: Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Others
• 4.5: ROW Fluorescent in Situ Hybridization (FISH) Market
  • 4.5.1: ROW Market by Product Type: Consumables, Instrument, and Software
  • 4.5.2: ROW Market by Application: Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Fluorescent in Situ Hybridization (FISH) Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Fluorescent in Situ Hybridization (FISH) Market by Technology
  • 6.1.3: Growth Opportunities for the Global Fluorescent in Situ Hybridization (FISH) Market by Application
  • 6.1.4: Growth Opportunities for the Global Fluorescent in Situ Hybridization (FISH) Market by End Use
  • 6.1.5: Growth Opportunities for the Global Fluorescent in Situ Hybridization (FISH) Market by Region
• 6.2: Emerging Trends in the Global Fluorescent in Situ Hybridization (FISH) Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Fluorescent in Situ Hybridization (FISH) Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Fluorescent in Situ Hybridization (FISH) Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abnova Corporation
• 7.2: Agilent Technologies
• 7.3: Biocare Medical
• 7.4: Biodot
• 7.5: F. Hoffmann-LA Roche
• 7.6: Genemed Technologies
• 7.7: Merck
• 7.8: PERKINELMER
• 7.9: Qiagen
• 7.10: Thermos Fisher Scientific